Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. - Rao,S.; Cunningham,D.; Hawkins,R.E. (Br J Cancer, 2005)